Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies (original) (raw)

Abstract

To characterize the region on human IgG1 responsible for its high-affinity interaction with the human Fc gamma receptor class I (Fc gamma RI), we have analyzed the binding properties of a series of genetically engineered chimeric antidinitrophenyl antibodies with identical murine antibody combining sites and hybrid IgG1/IgG2 human constant (C) regions. In addition, we have investigated a panel of reciprocally point-mutated IgG1 and IgG2 chimeric antibodies to identify the amino acid residues that confer cytophilic properties to human IgG1. Our data unambiguously indicate that cytophilic activity of IgG1 is an intrinsic property of its heavy-chain C region 2 (CH2) domain. We report that the entire sequence spanning residues 234-237 (LLGG) is required to restore full binding activity to IgG2 and IgG4 and that individual amino acid substitutions failed to render IgG2 active. Nevertheless, the reciprocal single point mutations in IgG1 either significantly lowered its activity or abolished it completely. Finally, we observed that an IgG2 antibody containing the entire ELLGGP sequence (residues 233-238) was more active than wild-type IgG1. This finding suggests that in addition to the primary contact site identified in the N terminus of the gamma 1 CH2 domain, secondary sites involving residues from the C-terminal half of the domain may also contribute to the IgG1-Fc gamma RI interaction.

9036

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C. L. Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes. J Exp Med. 1982 Dec 1;156(6):1794–1806. doi: 10.1084/jem.156.6.1794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker M. D., Pennell N., Bosnoyan L., Shulman M. J. Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6432–6436. doi: 10.1073/pnas.85.17.6432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnett Foster D. E., Dorrington K. J., Painter R. H. Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes. J Immunol. 1980 May;124(5):2186–2190. [PubMed] [Google Scholar]
  4. Berzofsky J. A., Schechter A. N. The concepts of crossreactivity and specificity in immunology. Mol Immunol. 1981 Aug;18(8):751–763. doi: 10.1016/0161-5890(81)90067-5. [DOI] [PubMed] [Google Scholar]
  5. Burton D. R. Immunoglobulin G: functional sites. Mol Immunol. 1985 Mar;22(3):161–206. doi: 10.1016/0161-5890(85)90151-8. [DOI] [PubMed] [Google Scholar]
  6. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 1981 Apr 28;20(9):2361–2370. [PubMed] [Google Scholar]
  7. Duncan A. R., Woof J. M., Partridge L. J., Burton D. R., Winter G. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature. 1988 Apr 7;332(6164):563–564. doi: 10.1038/332563a0. [DOI] [PubMed] [Google Scholar]
  8. Graziano R. F., Fanger M. W. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol. 1987 Nov 15;139(10):3536–3541. [PubMed] [Google Scholar]
  9. Jefferis R., Lund J., Pound J. Molecular definition of interaction sites on human IgG for Fc receptors (huFc gamma R). Mol Immunol. 1990 Dec;27(12):1237–1240. doi: 10.1016/0161-5890(90)90027-w. [DOI] [PubMed] [Google Scholar]
  10. Karpovsky B., Titus J. A., Stephany D. A., Segal D. M. Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies. J Exp Med. 1984 Dec 1;160(6):1686–1701. doi: 10.1084/jem.160.6.1686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Koolwijk P., Spierenburg G. T., Frasa H., Boot J. H., van de Winkel J. G., Bast B. J. Interaction between hybrid mouse monoclonal antibodies and the human high-affinity IgG FcR, huFc gamma RI, on U937. Involvement of only one of the mIgG heavy chains in receptor binding. J Immunol. 1989 Sep 1;143(5):1656–1662. [PubMed] [Google Scholar]
  12. Lund J., Tanaka T., Takahashi N., Sarmay G., Arata Y., Jefferis R. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. Mol Immunol. 1990 Nov;27(11):1145–1153. doi: 10.1016/0161-5890(90)90103-7. [DOI] [PubMed] [Google Scholar]
  13. Mosmann T. R., Baumal R., Williamson A. R. Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion. Eur J Immunol. 1979 Jul;9(7):511–516. doi: 10.1002/eji.1830090705. [DOI] [PubMed] [Google Scholar]
  14. Partridge L. J., Woof J. M., Jefferis R., Burton D. R. The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site on IgG. Mol Immunol. 1986 Dec;23(12):1365–1372. doi: 10.1016/0161-5890(86)90022-2. [DOI] [PubMed] [Google Scholar]
  15. Ratcliffe A., Stanworth D. R. The localization of the binding site(s) on human IgG1 for the Fc receptors on homologous monocytes and heterologous mouse macrophages. Immunology. 1983 Sep;50(1):93–100. [PMC free article] [PubMed] [Google Scholar]
  16. Raychaudhuri G., McCool D., Painter R. H. Human IgG1 and its Fc fragment bind with different affinities to the Fc receptors on the human U937, HL-60 and ML-1 cell lines. Mol Immunol. 1985 Sep;22(9):1009–1019. doi: 10.1016/0161-5890(85)90104-x. [DOI] [PubMed] [Google Scholar]
  17. Rinfret A., Horne C., Dorrington K. J., Klein M. Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment. Mol Immunol. 1989 Apr;26(4):431–434. doi: 10.1016/0161-5890(89)90133-8. [DOI] [PubMed] [Google Scholar]
  18. Rouzer C. A., Scott W. A., Kempe J., Cohn Z. A. Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4279–4282. doi: 10.1073/pnas.77.7.4279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shen L., Guyre P. M., Fanger M. W. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J Immunol. 1987 Jul 15;139(2):534–538. [PubMed] [Google Scholar]
  20. Shopes B., Weetall M., Holowka D., Baird B. Recombinant human IgG1-murine IgE chimeric Ig. Construction, expression, and binding to human Fc gamma receptors. J Immunol. 1990 Dec 1;145(11):3842–3848. [PubMed] [Google Scholar]
  21. Silverstein S. C., Steinman R. M., Cohn Z. A. Endocytosis. Annu Rev Biochem. 1977;46:669–722. doi: 10.1146/annurev.bi.46.070177.003321. [DOI] [PubMed] [Google Scholar]
  22. Tan L. K., Shopes R. J., Oi V. T., Morrison S. L. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. Proc Natl Acad Sci U S A. 1990 Jan;87(1):162–166. doi: 10.1073/pnas.87.1.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Taylor J. W., Ott J., Eckstein F. The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res. 1985 Dec 20;13(24):8765–8785. doi: 10.1093/nar/13.24.8765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Woof J. M. Fc receptors and their interaction with antibodies. Biochem Soc Trans. 1990 Apr;18(2):217–218. doi: 10.1042/bst0180217. [DOI] [PubMed] [Google Scholar]
  25. Woof J. M., Nik Jaafar M. I., Jefferis R., Burton D. R. The monocyte binding domain(s) on human immunoglobulin G. Mol Immunol. 1984 Jun;21(6):523–527. doi: 10.1016/0161-5890(84)90068-3. [DOI] [PubMed] [Google Scholar]
  26. Woof J. M., Partridge L. J., Jefferis R., Burton D. R. Localisation of the monocyte-binding region on human immunoglobulin G. Mol Immunol. 1986 Mar;23(3):319–330. doi: 10.1016/0161-5890(86)90059-3. [DOI] [PubMed] [Google Scholar]